Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Aug 29;9(1):e001854.
doi: 10.1136/bmjophth-2024-001854.

New horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors

Eric Lai  1 , Timothy Lee  2 , Claire Lee  3 , Sidney A Schechet  4
Affiliations
Editorial

New horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors

Eric Lai et al. BMJ Open Ophthalmol. .
No abstract available

Keywords: Clinical Trial; Degeneration; Macula; Pharmacology; Retina; Treatment Medical.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. Pegcetacoplan and avacincaptad pegol mechanisms of action in complement cascade inhibition.
See this image and copyright information in PMC

References

    1. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16. doi: 10.1016/S2214-109X(13)70145-1. - DOI - PubMed
    1. Boyer DS, Schmidt-Erfurth U, van Lookeren Campagne M, et al. THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET. Retina (Philadelphia, Pa) 2017;37:819–35. doi: 10.1097/IAE.0000000000001392. - DOI - PMC - PubMed
    1. Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13:438–51. doi: 10.1038/nri3459. - DOI - PMC - PubMed
    1. Kwak N, Okamoto N, Wood JM, et al. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41:3158–64. - PubMed
    1. Ba J, Peng R-S, Xu D, et al. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis. Drug Des Devel Ther. 2015;9:5397–405. doi: 10.2147/DDDT.S86269. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources